RxDoctor Payments Data

Dilpreet Bal, PA

Physician Assistant · Reno, NVNPI 1629470455

Payments from drug & device makers

$1,645in general payments, 2019–2025

Across 92 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$362
  • Boehringer Ingelheim$197
  • Esperion Therapeutics, Inc.$167
  • Amgen$165
  • Biohaven Pharmaceuticals, Inc.$111
  • GSK$99
  • plus $544 from 16 others

What the payments were for

  • Food & beverage$1,645100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,645 in reported general payments places this provider in the 70th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$637
Medicare patients
31
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin61$92,593
OzempicSemaglutide66$77,231
XeljanzTofacitinib Citrate11$65,532
TrulicityDulaglutide29$41,952
TradjentaLinagliptin27$29,690
SynjardyEmpagliflozin/Metformin Hcl17$27,202
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$21,339
EliquisApixaban18$18,042
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$7,636
Spiriva RespimatTiotropium Bromide12$7,295
SymbicortBudesonide/Formoterol Fumarate24$7,120
JanumetSitagliptin Phos/Metformin Hcl11$6,110
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$4,474
Albuterol Sulfate HfaAlbuterol Sulfate76$2,069
Atorvastatin Calcium236$1,957

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Synjardy, Spiriva Respimat$197$156,779117 claims
PfizerXeljanz, Eliquis$82$83,57429 claims
Novo NordiskOzempic$36$77,23166 claims
Lilly USA, LLCTrulicity$37$41,95229 claims
GSKTrelegy Ellipta$99$21,33924 claims
AstraZenecaSymbicort$14$7,12024 claims
MerckJanumet$83$6,11011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →